These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 386428)

  • 41. Release of two vasodilators, adenosine and prostacyclin, from isolated rabbit hearts during controlled hypoxia.
    Edlund A; Fredholm BB; Patrignani P; Patrono C; Wennmalm A; Wennmalm M
    J Physiol; 1983 Jul; 340():487-501. PubMed ID: 6350560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic disposition of prostacyclin in humans.
    Brash AR; Jackson EK; Saggese CA; Lawson JA; Oates JA; FitzGerald GA
    J Pharmacol Exp Ther; 1983 Jul; 226(1):78-87. PubMed ID: 6345756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of 6-keto-prostaglandin F1 alpha by rat granulosa cells in vitro.
    Koos RD; Clark MR
    Endocrinology; 1982 Nov; 111(5):1513-8. PubMed ID: 6813105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that prostacyclin modulates the vascular actions of calcium in man.
    Nadler JL; McKay M; Campese V; Vrbanac J; Horton R
    J Clin Invest; 1986 Apr; 77(4):1278-84. PubMed ID: 3514678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostacyclin, prostaglandin F2 alpha and progesterone production by bovine luteal cells during the estrous cycle.
    Milvae RA; Hansel W
    Biol Reprod; 1983 Dec; 29(5):1063-8. PubMed ID: 6418223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal degradation and distribution between urinary and venous output of prostaglandins E2 and I2.
    Bugge JF; Vikse A; Dahl E; Kiil F
    Acta Physiol Scand; 1987 Jul; 130(3):467-74. PubMed ID: 3307303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.
    Czervionke RL; Smith JB; Fry GL; Hoak JC; Haycraft DL
    J Clin Invest; 1979 May; 63(5):1089-92. PubMed ID: 376548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostacyclin metabolites in human plasma.
    Rosenkranz B; Fischer C; Frölich JC
    Clin Pharmacol Ther; 1981 Mar; 29(3):420-4. PubMed ID: 7009022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isolation of prostacyclin from whole blood.
    Skrinska V; Lucas FV
    Prostaglandins; 1981 Sep; 22(3):365-75. PubMed ID: 7029655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentrations of the prostacyclin metabolite, 6-keto-prostaglandin F1 alpha, in amniotic fluid during late pregnancy and labour.
    Mitchell MD; Keirse MJ; Brunt JD; Anderson AB; Turnbull AC
    Br J Obstet Gynaecol; 1979 May; 86(5):350-3. PubMed ID: 380629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atherosclerosis decreased prostacyclin formation in rabbit lungs and kidneys.
    Dembińska-Kieć A; Rücker W; Schönhöfer PS
    Prostaglandins; 1979 Jun; 17(6):831-8. PubMed ID: 388529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant inhibition of pulsatile luteinizing hormone (LH) and stimulation of prolactin release by prostacyclin (PGI2) in ovariectomized (OVX) conscious rats.
    Ottlecz A; McCann SM
    Life Sci; 1988; 43(25):2077-85. PubMed ID: 3062293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eicosapentaenoic acid inhibits the release of 14C-prostacyclin from a perfused tissue after incorporation of 14C-prostaglandin precursors.
    Juan H; Sametz W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):388-93. PubMed ID: 2993925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct age-related changes in the urinary catabolic profile of prostaglandin F2 alpha in the rat.
    Pace-Asciak CR; Edwards NS
    J Biol Chem; 1980 Jul; 255(13):6106-10. PubMed ID: 7391007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of PGE2, 6-keto PGF1 alpha and renin release from dog kidneys.
    Bugge JF; Vikse A; Dahl E; Slørdahl SH; Kiil F
    Acta Physiol Scand; 1986 Jun; 127(2):197-205. PubMed ID: 3088915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
    Wong PY; Chao PH; McGiff JC
    J Pharmacol Exp Ther; 1982 Dec; 223(3):757-60. PubMed ID: 6754908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostacyclin (PGI2) effects on anterior pituitary hormones in the rat in vivo.
    Kimball FA; Porteus SE; Kirton KT; Frielink RD; Creasy DM; Dayan AD
    Prostaglandins; 1979 Sep; 18(3):377-85. PubMed ID: 394197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation of effects of xanthine analogs on renal prostaglandins and renal excretory function in the awake rat.
    Baer PG; Armstrong EL; Cagen LM
    J Pharmacol Exp Ther; 1983 Dec; 227(3):600-4. PubMed ID: 6581288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cigarette smoking inhibits prostacyclin formation.
    Nadler JL; Velasco JS; Horton R
    Lancet; 1983 Jun; 1(8336):1248-50. PubMed ID: 6134041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of uninephrectomy on urinary prostaglandin E2, F2 alpha, and 6-ketoprostaglandin F1 alpha excretion in rats.
    Baer PG; Nasjletti A
    Clin Sci (Lond); 1984 Apr; 66(4):407-13. PubMed ID: 6583033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.